Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

17 Feb 2022 14:55

RNS Number : 0473C
B.P. Marsh & Partners PLC
17 February 2022
Β 

Date: 17th February 2022

Β 

B.P. Marsh & Partners Plc

PDMR and Director Dealings

Β 

B.P. Marsh (AIM: BPM),Β the specialist investor in early-stage financial services businesses,Β announces that it has been notified that Mr. Daniel Topping, Chief Investment Officer, has traded in the ordinary shares ofΒ 10 penceΒ each in the Company ("Ordinary Shares").

Β 

The Company has been made aware that Mr. Topping on 16th February 2022 purchased 1,488 Ordinary Shares for 324.89p per share, or an aggregate of Β£4,834.36. As a resultΒ of the transaction, Daniel has a beneficial interest in 122,369 Ordinary Shares (including 11,434 shares owned by his wife Claire Cronin), together with a beneficial interest in 18,660 Ordinary Shares held in the Company's SIP Trust, representing in aggregate approximately 0.38% of the total voting rights of the Company.

Β 

Additionally, Daniel, as part of the Company's Joint Share Ownership Plan, has a beneficial interest (as a joint owner alongside JTC Employer Solutions Trustee) over 167,465 Ordinary Shares, representing approximately 0.45% of the total voting rights of the Company.

Β 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Β 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Chief Investment Officer, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares ofΒ 10 penceΒ each

Β 

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Purchase of Ordinary Shares via SIPP

c)

Price(s) and volumes(s)

Β 

Price(s)

Β£3.25

Volume(s)

1,488

Β 

Β 

Β 

d)

Aggregated information

N/A

e)

Date of the transaction

22-02-16

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

Β 

Β 

For further information:

Β 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

Β 

+44 (0)20 7233 3112

Β 

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

Β 

Atholl TweedieΒ / Charles Leigh-Pemberton / Ailsa Macmaster

Β 

Financial PR/Investor Relations

Tavistock

Simon Hudson / Tim Pearson

+44 (0)20 7886 2500

Β 

Β 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

Β 

Β 

Notes to Editors:

About B.P. Marsh & Partners Plc

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found atΒ www.bpmarsh.co.uk.

Β 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Several of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

Β 

- Ends -

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBSGDDXUBDGDR
Date   Source Headline
24th Jun 20212:00 pmRNSShare Incentive Plan
8th Jun 20212:41 pmRNSDirector/PDMR Shareholding
8th Jun 20217:00 amRNSFinal Results
12th Apr 20214:07 pmRNSHolding(s) in Company
12th Apr 20214:06 pmRNSHolding(s) in Company
12th Apr 20214:05 pmRNSDirector/PDMR Shareholding
9th Apr 20215:26 pmRNSDirector/PDMR Shareholding
31st Mar 20213:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSInvestee Company Update
4th Mar 20215:50 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSB.P. Marsh Trading Update
29th Jan 20215:11 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSInvestee Company Update: ATC Insurance Solutions
11th Jan 20217:00 amRNSInvestee Company Update - Nexus Underwriting
6th Jan 20215:39 pmRNSDirector/PDMR Shareholding
6th Jan 202112:04 pmRNSInvestee Company Update - XPT Group LLC
22nd Dec 20203:27 pmRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSInvestee Company Update – Nexus Underwriting
19th Nov 20207:00 amRNSInvestee Company Update – Lilley Plummer Risks
27th Oct 202010:37 amRNSDirector/PDMR Shareholding
14th Oct 20203:54 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSInterim Results
23rd Sep 20203:01 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSTrading Update
4th Sep 20209:42 amRNSInvestee Company Update: LEBC
25th Aug 202010:36 amRNSInvestee Company Update
14th Aug 202011:41 amRNSDirector/PDMR Shareholding
13th Aug 202010:56 amRNSHolding(s) in Company
12th Aug 20204:14 pmRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSFurther Progress at US Investee Company XPT Group
27th Jul 20204:13 pmRNSDirector/PDMR Shareholding
20th Jul 20205:05 pmRNSResult of AGM
13th Jul 20209:16 amRNSDubai International Financial Centre – EC3 Brokers
30th Jun 20203:21 pmRNSDirector/PDMR Shareholding
29th Jun 20207:00 amRNSInvestment – SAGE Program Underwriters
26th Jun 20203:04 pmRNSNotice of AGM
26th Jun 20209:28 amRNSDirector/PDMR Shareholding
23rd Jun 202012:27 pmRNSTotal Voting Rights
10th Jun 20202:05 pmRNSSecond Price Monitoring Extn
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202011:36 amRNSDirector/PDMR Shareholding
9th Jun 20207:00 amRNSFinal Results
30th Apr 202012:41 pmRNSPortfolio Update
23rd Apr 202010:50 amRNSTotal Voting Rights
23rd Apr 20209:22 amRNSInvestee Company Acquisition
30th Mar 20205:52 pmRNSDirector/PDMR Shareholding
24th Mar 20204:05 pmRNSDirector/PDMR Shareholding
20th Mar 202010:47 amRNSDirector/PDMR Shareholding
13th Mar 20201:52 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSInvestee Company Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.